Intellia Therapeutics Inc (NTLA)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 13.27M | 13.57M | 12.61M | 13.59M | 11.99M | -1.92M | 28.94M | 6.96M |
営業利益 | -107.36M | -113.34M | -115.01M | -136.33M | -134.96M | -144.62M | -114M | -139.04M |
税引前収入 | -113.23M | -113.41M | -103.13M | -123.68M | -122.22M | -132.16M | -107.44M | -146.98M |
純利益 | -113.23M | -113.41M | -103.13M | -123.68M | -122.22M | -132.16M | -107.44M | -146.98M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -115.17M | -118.76M | -115.11M | -136.33M | -134.96M | -144.62M | -114M | -139.04M |
EBITDA | -105.41M | -111.3M | -112.96M | -134.16M | -132.67M | -142.15M | -111.49M | -136.44M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 16.48M | 26.12M | 30.43M | 43.1M | 57.99M | 33.05M | 52.12M | 36.28M |
営業利益 | -32.16M | -69.56M | -90.87M | -106.37M | -136.58M | -269.18M | -469.24M | -530.92M |
税引前収入 | -31.63M | -67.54M | -85.34M | -99.53M | -134.23M | -267.89M | -474.19M | -481.19M |
純利益 | -31.63M | -67.54M | -85.34M | -99.53M | -134.23M | -267.89M | -474.19M | -481.19M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.878 | -1.594 | -1.887 | -1.983 | -2.027 | -3.597 | -5.444 | -5.373 |
EBIT | -32.16M | -69.56M | -90.87M | -106.37M | -136.58M | -269.18M | -482.73M | -531.02M |
EBITDA | -31.06M | -66.56M | -86.41M | -100.78M | -130.27M | -262.28M | -461.67M | -521.95M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約